Comparison of Dapagliflozin (DAPA) and Once-weekly Exenatide (EQW), Co-administered or Alone, DAPA/ Glucophage (DAPA/MET ER) and Phentermine/Topiramate (PHEN/TPM) ER on Metabolic Profiles and Body Composition in Obese PCOS Women
Phase of Trial: Phase III
Latest Information Update: 11 May 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Dapagliflozin/metformin (Primary) ; Exenatide (Primary) ; Phentermine/topiramate
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 08 May 2017 Planned End Date changed from 1 Sep 2018 to 1 Apr 2019.
- 08 May 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jan 2019.